Q4 2025 Holdings
Filed 2026-02-12 | 13 holdings | $706.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Zenas BioPharma, Inc(ZBIO) | Common Stock | 98937L105 | $182.9M | 5,037,854 | 25.9% |
| Arcellx, Inc.(ACLX) | Common Stock | 03940C100 | $153.0M | 2,346,630 | 21.7% |
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $106.9M | 2,038,763 | 15.1% |
| Design Therapeutics, Inc.(DSGN) | Common Stock | 25056L103 | $61.2M | 6,526,476 | 8.7% |
| Mineralys Therapeutics Inc.(MLYS) | Common Stock | 603170101 | $56.8M | 1,563,966 | 8.0% |
| ARS Pharmaceuticals, Inc.(SPRY) | Common Stock | 82835W108 | $46.8M | 4,012,903 | 6.6% |
| Oric Pharmaceuticals, Inc.(ORIC) | Common Stock | 68622P109 | $37.8M | 4,514,929 | 5.3% |
| Alumis Inc.(ALMS) | Common Stock | 022307102 | $19.1M | 1,959,896 | 2.7% |
| Oruka Therapeutics, Inc(ORKA) | Common Stock | 687604108 | $13.0M | 430,330 | 1.8% |
| Oculis Holding AG(OCS) | Ordinary Shares | H5870P102 | $12.8M | 641,022 | 1.8% |
| enGene Holdings Inc.(ENGN) | Common Shares | 29286M105 | $6.8M | 747,750 | 1.0% |
| Nkarta, Inc.(NKTX) | Common Stock | 65487U108 | $6.2M | 3,333,333 | 0.9% |
| Ultragenyx Pharmaceutical Inc.(RARE) | Common Stock | 90400D108 | $3.2M | 137,753 | 0.4% |